AI assistant
Sanara MedTech Inc. — Director's Dealing 2021
Sep 30, 2021
33339_dirs_2021-09-30_c0311cae-2c12-450b-8b33-e68477661824.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2021-09-28
Reporting Person: Bowman Shawn M. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-28 | Common Stock | S | 1000 | $33.33 | Disposed | 16668 | Direct |
Footnotes
F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2021.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.15 to $33.41, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.